Athersys is seeking a Bio-Pharmaceutical Manufacturing Manager to join our team. For more information and to apply: https://lnkd.in/eWJyCff
Athersys - Careers
Institutional ownership has gone up by 10% in the last week to almost 22,000,000.
Looks like Gnate (and his short buddies) was wrong. A Summer decline to the $1.00 range is very unlikely at this point.
institutional ownership is not the same as insider ownership. It is the buying at market price that has driven up the price by 10% in the last week. We need institutional ownership to keep rising. If it does the stock price will hit new highs.
From a tech analysis point of view. Monthly chart has been shaping up nicely. Long term trend line sits somewhere between 1.90-2.00 for the month of August. Dropping @ 7 pips per month. We will need some sort of catalyst to break through. However Being a forward looking mechanism it wouldn't surprise me if we didn't at least test those levels in the coming months and give us a new trading range until fundamentals ultimately set the stage.
Something is brewing...glad i am already on-board! hoping for a major payday within 2-3 years.
MAXM raises price target from 9 to 12 bucks!!!!! Giddy up!
Good report. Things looking good going forward, esp financial.
I have seen China mentioned a couple of times but have been unable to find any news about it myself. Can someone tell me what is going on with China?
Again, good buying opp..BUT, don't expect major up-tick until the company makes money. Lots of "hype now" but potential remain based on 3 areas evaluating efficacious results. GLTA. .
Bayarea, the big boys on WS own over 20,000.000 shares of ATHX. Prudential, BlackRock, Vanguard, ect,.... How much support you want?
Another dump and I'm out @26K
I hope with a new partnership announcement we get to hear from WST again. He has done a tremendous amount of due diligence and written great S.A. articles on Athersys.
Sorry shorts........you will take it in the shorts, today......no looking back.......the World is ganging up on stroke with this company and will take on myocardial infarction, next............GLTAL.........
Not much reaction in the after hours market with the good results and a good report.
Athersys Reports Alignment of Key Regulators for Pivotal Registration Study in Stroke - NASDAQ.com
MultiStem ® stem cell technology receives Positive Opinion from European Medicines Agency. Adds to Special Protocol Assessment and Fast Track.
On the call yesterday there were only a few analyst, all working for the company. Seems a little fishy to me. This company has no support from anyone on ws or large institutions. When is that going to change?
I was expecting a little more of a pop on this news. Institutional ownership has recently grown over 5 million shares recently too.
According to the SEC filings it looks like Gil and Bill have recently purchased sizable shares in June. That's a good sign since I'm not aware of such activity in the past.
The science is notable but the results is not definitive. Together, the opportunity to buy is now if the report this week is even Slightly positive. Shorts will always play the game until they get caught w/their pants down Long term holder-patience like w/any stock coupled w/DD. ALL in MHO for what its worth going forward.